Acorn Capital Advisors, LLC
19 holdingsFiling period: 2026-06-30Current AUM: $320.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology Inc | 1.13M | $80.4M | $70.1M | 21.84% | +999 | 2026-06-30 |
| 2 | — | Urogen Pharma Ltd | 1.67M | $61.6M | $61.6M | 19.19% | -- | 2026-06-30 |
| 3 | TRVI | Trevi Therapeutics Inc | 2.14M | $40.0M | $27.5M | 8.58% | -- | 2026-06-30 |
| 4 | CADL | Candel Therapeutics Inc | 3.50M | $36.0M | $30.2M | 9.42% | -- | 2026-06-30 |
| 5 | PBYI | Puma Biotechnology Inc | 4.13M | $33.5M | $44.5M | 13.85% | -- | 2026-06-30 |
| 6 | JBIO | Jade Biosceinces Inc | 986.8K | $21.9M | $14.7M | 4.57% | +200.0K | 2026-06-30 |
| 7 | BCAX | Bicara Therapeutics | 643.4K | $19.1M | $11.8M | 3.68% | -1 | 2026-06-30 |
| 8 | KPTI | Karyopharm Therapeutics Inc | 1.52M | $14.8M | $544K | 0.17% | +1.23M | 2026-06-30 |
| 9 | OKUR | Onkure Therapeutics Inc | 2.84M | $12.9M | $6.7M | 2.09% | -- | 2026-06-30 |
| 10 | HELP | Helus Pharma Inc. | 1.54M | $10.2M | $16.9M | 5.25% | -- | 2026-06-30 |
| 11 | TARA | Protara Therapeutics Inc | 1.75M | $6.7M | $4.5M | 1.40% | -- | 2026-06-30 |
| 12 | AURA | Aura Biosciences Inc | 929.1K | $6.6M | $6.1M | 1.90% | +333.3K | 2026-06-30 |
| 13 | LONA | Leonabio, Inc. | 634.5K | $5.8M | $3.3M | 1.04% | -- | 2026-06-30 |
| 14 | VSTM | Verastem Inc | 1.47M | $5.6M | $13.7M | 4.28% | -- | 2026-06-30 |
| 15 | WHWK | Whitehawk Therapeutics Inc | 1.14M | $5.2M | $3.6M | 1.13% | -- | 2026-06-30 |
| 16 | QTTB | Q32 Bio Inc. | 216.2K | $2.8M | $1.9M | 0.58% | -98,881 | 2026-06-30 |
| 17 | ENGN | Eugene Therapeutics | 1.27M | $2.2M | $2.1M | 0.66% | -- | 2026-06-30 |
| 18 | JSPR | Jasper Therapeutics | 1.44M | $604K | $717K | 0.22% | +26.7K | 2026-06-30 |
| 19 | BCAB | Bioatla Inc | 108.1K | $447K | $447K | 0.14% | -5,298,219 | 2026-06-30 |
← Scroll →